Afrezza is a Respiratory (inhalation) Powder, Metered in the Human Prescription Drug category. It is labeled and distributed by Mannkind Corporation. The primary component is Insulin Human.
| Product ID | 47918-874_08004666-044b-493c-8643-1ac2ba6a2ac4 |
| NDC | 47918-874 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Afrezza |
| Generic Name | Insulin Human |
| Dosage Form | Powder, Metered |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2014-07-11 |
| Marketing Category | BLA / NDA |
| Application Number | BLA022472 |
| Labeler Name | Mannkind Corporation |
| Substance Name | INSULIN HUMAN |
| Active Ingredient Strength | 4 1/1 |
| Pharm Classes | Insulin [EPC],Insulin [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2014-07-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA022472 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-07-11 |
| Ingredient | Strength |
|---|---|
| INSULIN HUMAN | 4 1/1 |
| SPL SET ID: | 29f4637b-e204-425b-b89c-7238008d8c10 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 47918-874 | Afrezza | Insulin Human |
| 47918-880 | Afrezza | Afrezza |
| 47918-878 | Afrezza | Afrezza |
| 47918-894 | Afrezza | Afrezza |
| 47918-898 | Afrezza | Afrezza |
| 47918-891 | Afrezza | Afrezza |
| 47918-902 | Afrezza | Afrezza |
| 47918-882 | Afrezza | Afrezza |
| 0002-8215 | Humulin | Insulin human |
| 0002-8315 | Humulin | Insulin human |
| 0002-8501 | Humulin | Insulin human |
| 0002-8715 | Humulin | Insulin human |
| 0002-8803 | Humulin | Insulin human |
| 0002-8805 | Humulin | Insulin human |
| 0002-8824 | Humulin | Insulin human |
| 0338-0126 | MYXREDLIN | insulin human |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AFREZZA 77808079 3858037 Live/Registered |
MannKind Corporation 2009-08-19 |